Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation

Response by David Taggart, MD, PhD to the EXCEL Statement

Presenter: David Taggart

December 19, 2019

Presentation TCT Abstracts Posters 2019

Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock

Presenter: Luis Nombela-Franco

September 29, 2019

Presentation TCT 2019

DEFINE-LM Registry: Revascularization Deferral in Patients With Left Main Coronary Artery Disease Based on iFR Evaluation

Presenter: Takayuki Warisawa

September 28, 2019

Presentation TCT 2019

EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

How to Approach LM Trifurcation Disease

Presenter: Jean Fajadet

September 27, 2019

Presentation TCT 2019

Heart Team Case Discussions for 2 Patients With Left Main Bifurcation Disease

Presenter: Matthew Cavender

September 27, 2019

Presentation TCT 2019

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Presenter: Robert-Jan Van Geuns

September 26, 2019

Presentation TCT 2019

TCT 71: Impact of Intravascular Ultrasound Guidance on Long-Term (10-Year) Mortality and Adverse Cardiovascular Events in Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease

Presenter: Do-Yoon Kang

September 25, 2019

Presentation TCT 2019

Case 4 (From S. Korea): Upfront 3 Stent for Left Main Trifurcation Disease

Presenter: Seung-Jung Park

September 25, 2019

Presentation TCT 2019

Case Example: A Complex Left Main Bifurcation

Presenter: Gennaro Giustino

September 25, 2019

Presentation TCT 2019

Left Main and Bifurcation Interventions

Presenter: Ehtisham Mahmud

September 25, 2019

Presentation Fellows 2019

Left Main Disease: Why I Do It How I Do It

Presenter: Jeffrey Moses

April 13, 2019

Presentation CHIP at ACC 2019

Update on PCI for Left Main and Multivessel Disease

Presenter: Gregg W. Stone

March 15, 2019

Presentation JIM 2019

Clinical scenario and context: A stable patient with LM involvement and MV disease

Presenter: Gianluca Campo

February 13, 2019

Presentation BIT 2019

When PCI and When CABG in the Year 2019

Presenter: Afzalur Rahman

February 08, 2019

Presentation BIT 2019

Not All Left Main Disease is Atherosclerotic

Presenter: Gary S. Mintz

February 08, 2019

Presentation Cardiovascular Interventions 2018

PCI Vs CABG for Multivessel and Unprotected LM Disease

Presenter: Paul S. Teirstein

October 26, 2018

Presentation Cardiovascular Interventions 2018

FFR/NHPR (eg, iFR) Caveats: Real World Challenges – Left Main, Diffuse Disease, CTOs

Presenter: Morton J. Kern

October 26, 2018

Advertisement

Response by David Taggart, MD, PhD to the EXCEL Statement

Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock

DEFINE-LM Registry: Revascularization Deferral in Patients With Left Main Coronary Artery Disease Based on iFR Evaluation

EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

How to Approach LM Trifurcation Disease

Heart Team Case Discussions for 2 Patients With Left Main Bifurcation Disease

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

TCT 71: Impact of Intravascular Ultrasound Guidance on Long-Term (10-Year) Mortality and Adverse Cardiovascular Events in Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease

Case 4 (From S. Korea): Upfront 3 Stent for Left Main Trifurcation Disease

Case Example: A Complex Left Main Bifurcation

Left Main and Bifurcation Interventions

Left Main Disease: Why I Do It How I Do It

Update on PCI for Left Main and Multivessel Disease

Clinical scenario and context: A stable patient with LM involvement and MV disease

When PCI and When CABG in the Year 2019

Not All Left Main Disease is Atherosclerotic

PCI Vs CABG for Multivessel and Unprotected LM Disease

FFR/NHPR (eg, iFR) Caveats: Real World Challenges – Left Main, Diffuse Disease, CTOs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content